Annual Drug Patent Expirations for SKELAXIN
Skelaxin is a drug marketed by King Pharms and is included in one NDA. It is available from four suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for SKELAXIN.
This drug has two patent family members in two countries.
The generic ingredient in SKELAXIN is metaxalone. Four suppliers are listed for this compound. Additional details are available on the metaxalone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
